BackgroundThis gene encodes the enzyme responsible for RNA editing by site-specific deamination of adenosines. This enzyme destabilizes double-stranded RNA through conversion of adenosine to inosine. Mutations in this gene have been associated with dyschromatosis symmetrica hereditaria. Alternative splicing results in multiple transcript variants.
DescriptionADAR Recombinant Monoclonal Antibody [7H12]. Unconjugated. Raised in: HEK293F Cell.
FormulationBuffer: Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
SpecificityHuman
IsotypeRabbit IgG
Uniprot IDP55265
PurificationAffinity Chromatography
ImmunogenA synthesized peptide derived from human ADAR1
StorageUpon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Alternative NamesDouble-stranded RNA-specific adenosine deaminase (DRADA) (EC 3.5.4.37) (136 kDa double-stranded RNA-binding protein) (p136) (Interferon-inducible protein 4) (IFI-4) (K88DSRBP), ADAR, ADAR1 DSRAD G1P1 IFI4
ApplicationELISA, IHC; Recommended dilution: IHC:1:50-1:200